Matthew Kaplan

Insider Reports History

Entity
Individual
Location
C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, Fort Lee, NJ
Signature
/s/ Matthew Kaplan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Kaplan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvectis Pharma, Inc. Director Common Stock 83.8K $565K $6.74 Jun 13, 2024 Direct

Insider Reports Filed by Matthew Kaplan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVCT Nuvectis Pharma, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
NVCT Nuvectis Pharma, Inc. Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
NVCT Nuvectis Pharma, Inc. May 12, 2022 2 $50.6K 4 May 16, 2022 Director
NVCT Nuvectis Pharma, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
NVCT Nuvectis Pharma, Inc. Feb 8, 2022 0 $0 3 Feb 8, 2022 Director